Fibroblast growth factor 21, adiposity, and macronutrient balance in a healthy, pregnant population with overweight and obesity

References

• Kharitonenkov A, Shiyanova TL, Koester A, et al. FGF-21 as a novel metabolic regulator. J Clin Invest. 2005;115(6):1627–1635. DOI:10.1172/JCI23606.
   PubMed Web of Science ®Google Scholar
• Coskun T, Bina HA, Schneider MA, et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology. 2008;149(12):6018–6027. DOI:10.1210/en.2008-0816.
   PubMed Web of Science ®Google Scholar
• Xu J, Lloyd DJ, Hale C, et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes. 2009;58(1):250–259. DOI:10.2337/db08-0392.
   PubMed Web of Science ®Google Scholar
• Camporez JP, Jornayvaz FR, Petersen MC, et al. Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice. Endocrinology. 2013;154(9):3099–3109. DOI:10.1210/en.2013-1191.
   PubMed Web of Science ®Google Scholar
• Kharitonenkov A, Wroblewski VJ, Koester A, et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology. 2007;148(2):774–781. DOI:10.1210/en.2006-1168.
   PubMed Web of Science ®Google Scholar
• Gaich G, Chien JY, Fu H, et al. The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metab. 2013;18(3):333–340. DOI:10.1016/j.cmet.2013.08.005.
   PubMed Web of Science ®Google Scholar
• Wente W, Efanov AM, Brenner M, et al. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes. 2006;55(9):2470–2478. DOI:10.2337/db05-1435.
   PubMed Web of Science ®Google Scholar
• Chavez AO, Molina-Carrion M, Abdul-Ghani MA, Folli F, Defronzo RA, Tripathy D. Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance. Diabetes Care. 2009;32(8):1542–1546.
   PubMed Web of Science ®Google Scholar
• Chen WW, Li L, Yang GY, et al. Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2008;116(1):65–68. DOI:10.1055/s-2007-985148.
   PubMed Web of Science ®Google Scholar
• Mraz M, Bartlova M, Lacinova Z, et al. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity. Clin Endocrinol (Oxf). 2009;71(3):369–375. DOI:10.1111/j.1365-2265.2008.03502.x.
   PubMed Web of Science ®Google Scholar
• Lin Z, Wu Z, Yin X, et al. Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile. PLoS One. 2010;5(12):e15534. DOI:10.1371/journal.pone.0015534.
   PubMed Web of Science ®Google Scholar
• Chen C, Cheung BM, Tso AW, et al. High plasma level of fibroblast growth factor 21 is an Independent predictor of type 2 diabetes: a 5.4-year population-based prospective study in Chinese subjects. Diabetes Care. 2011;34(9):2113–2115. DOI:10.2337/dc11-0294.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xie Y, Berglund ED, et al. The starvation hormone, fibroblast growth factor-21, extends lifespan in mice. Elife. 2012;1:e00065.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yeung DC, Karpisek M, et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes. 2008;57(5):1246–1253. DOI:10.2337/db07-1476.
   PubMed Web of Science ®Google Scholar
• Dushay J, Chui PC, Gopalakrishnan GS, et al. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology. 2010;139(2):456–463. DOI:10.1053/j.gastro.2010.04.054.
   PubMed Web of Science ®Google Scholar
• Li L, Yang G, Ning H, Yang M, Liu H, Plasma CW. FGF-21 levels in type 2 diabetic patients with ketosis. Diabetes Res Clin Pract. 2008;82(2):209–213.
   PubMed Web of Science ®Google Scholar
• Li K, Li L, Yang M, Zong H, Liu H, Yang G. Effects of rosiglitazone on fasting plasma fibroblast growth factor-21 levels in patients with type 2 diabetes mellitus. Eur J Endocrinol. 2009;161(3):391–395.
   PubMed Web of Science ®Google Scholar
• Tan BK, Hallschmid M, Adya R, Kern W, Lehnert H, Randeva HS. Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity. Diabetes. 2011;60(11):2758–2762.
   PubMed Web of Science ®Google Scholar
• Stein S, Stepan H, Kratzsch J, et al. Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia. Metabolism. 2010;59(1):33–37. DOI:10.1016/j.metabol.2009.07.003.
   PubMed Web of Science ®Google Scholar
• Gallego-Escuredo JM, Gomez-Ambrosi J, Catalan V, et al. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients. Int J Obes (Lond). 2015;39(1):121–129. DOI:10.1038/ijo.2014.76.
   PubMed Web of Science ®Google Scholar
• Li H, Bao Y, Xu A, et al. Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects. J Clin Endocrinol Metab. 2009;94(6):2151–2156. DOI:10.1210/jc.2008-2331.
   PubMed Web of Science ®Google Scholar
• Wang D, Zhu W, Li J, An C, Wang Z. Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history. PLoS One. 2013;8(11):e81190.
   PubMed Web of Science ®Google Scholar
• Stepan H, Kley K, Hindricks J, et al. Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia. Cytokine. 2013;62(2):322–326. DOI:10.1016/j.cyto.2013.02.019.
   PubMed Web of Science ®Google Scholar
• Tan BK, Sivakumar K, Bari MF, Vatish M, Randeva HS. Lower cerebrospinal fluid/plasma fibroblast growth factor 21 (FGF21) ratios and placental FGF21 production in gestational diabetes. PLoS One. 2013;8(6):e65254.
   PubMed Web of Science ®Google Scholar
• Li SM, Wang WF, Zhou LH, et al. Fibroblast growth factor 21 expressions in white blood cells and sera of patients with gestational diabetes mellitus during gestation and postpartum. Endocrine. 2015;48(2):519–527. DOI:10.1007/s12020-014-0309-8.
   PubMed Web of Science ®Google Scholar
• Megia A, Gil-Lluis P, Naf S, et al. Cord blood FGF21 in gestational diabetes and its relationship with postnatal growth. Acta Diabetol. 2015;52(4):693–700. DOI:10.1007/s00592-014-0705-9.
   PubMed Web of Science ®Google Scholar
• Sutton EF, Cain LE, Vallo PM, Redman LM. Strategies for successful recruitment of pregnant patients into clinical trials. Obstet Gynecol. 2017;129(3):554–559.
   PubMed Web of Science ®Google Scholar
• ACOG Committee opinion. Number 267, January 2002: exercise during pregnancy and the postpartum period. Obstet Gynecol. 2002;99(1):171–173.
   PubMed Web of Science ®Google Scholar
• Marshall NE, Murphy EJ, King JC, et al. Comparison of multiple methods to measure maternal fat mass in late gestation. Am J Clin Nutr. 2016;103(4):1055–1063. DOI:10.3945/ajcn.115.113464.
   PubMed Web of Science ®Google Scholar
• van Raaij JM, Peek ME, Vermaat-Miedema SH, Schonk CM, Hautvast JG. New equations for estimating body fat mass in pregnancy from body density or total body water. Am J Clin Nutr. 1988;48(1):24–29.
   PubMed Web of Science ®Google Scholar
• Dekker Nitert M, Barrett HL, Kubala MH, et al. Increased placental expression of fibroblast growth factor 21 in gestational diabetes mellitus. J Clin Endocrinol Metab. 2014;99(4):E591–598. DOI:10.1210/jc.2013-2581.
   PubMed Web of Science ®Google Scholar
• Dekker Nitert M, Scholz-Romero K, Kubala MH, McIntyre HD, Callaway LK, Barrett HL. Placental fibroblast growth factor 21 is not altered in late-onset preeclampsia. Reprod Biol Endocrinol. 2015;13:14.
   PubMed Web of Science ®Google Scholar
• Cui Y, Giesy SL, Hassan M, Davis K, Zhao S, Boisclair YR. Hepatic FGF21 production is increased in late pregnancy in the mouse. Am J Physiol Regul Integr Comp Physiol. 2014;307(3):R290–298.
   PubMed Web of Science ®Google Scholar
• Dutchak PA, Katafuchi T, Bookout AL, et al. Fibroblast growth factor-21 regulates PPARgamma activity and the antidiabetic actions of thiazolidinediones. Cell. 2012;148(3):556–567. DOI:10.1016/j.cell.2011.11.062.
   PubMed Web of Science ®Google Scholar